Sanofi Switch Gives UK Hay Fever Sufferers Additional Mass Market Option
Sanofi has switched its Allevia hay fever tablets (fexofenadine hydrochloride) in the UK, from prescription-only to general sales list status.
You may also be interested in...
J&J switches its Benacort hayfever nasal spray from prescription-only to general sales list status in the UK, making it the third mass market steriod-based spray available outside pharmacy.
“You can’t just live off the brand equity anymore,” warned J&J's Consumer Health's Manoj Raghunandanan during the ‘Advancing Trust in the Self-Care Industry’ webinar co-hosted by the Global Self-Care Federation and HBW Insight. “You’ve got to continue to build that trust between consumers and products day-in day-out.”
The Global Self-Care Federation is looking to consolidate the shift towards self-care seen during the pandemic by promoting trust, innovation and growth in policy. An upcoming webinar hosted by the GSCF will also explore the theme of "Advancing Trust in the Self-Care Industry."